Real-time enrollment status for this meningiomas clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:45 AM UTC
| NCT Number | NCT02523014 |
| Recruiting Status | Recruiting |
| Condition | Meningiomas |
| Phase | PHASE2 |
| Target Enrollment | 124 participants |
| Active Locations | 784 sites in the US |
| Sponsor | Alliance for Clinical Trials in Oncology |
| Last Updated on CT.gov | October 2, 2026 (2 weeks ago) |
As of October 16, 2026: Clinical trial NCT02523014 is currently recruiting participants. This phase2 study for meningiomas is actively seeking new participants at 784 locations across the United States. The study is sponsored by Alliance for Clinical Trials in Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02523014 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 784 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02523014 was last updated 2 weeks ago (October 2, 2026). HelloStudys verifies this status automatically.